Page last updated: 2024-10-16

quinacrine and Ebola Hemorrhagic Fever

quinacrine has been researched along with Ebola Hemorrhagic Fever in 2 studies

Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Lane, TR2
Dyall, J1
Mercer, L1
Goodin, C1
Foil, DH1
Zhou, H1
Postnikova, E1
Liang, JY1
Holbrook, MR1
Madrid, PB2
Ekins, S2
Comer, JE1
Freiberg, AN1

Other Studies

2 other studies available for quinacrine and Ebola Hemorrhagic Fever

ArticleYear
Repurposing Pyramax®, quinacrine and tilorone as treatments for Ebola virus disease.
    Antiviral research, 2020, Volume: 182

    Topics: Antiviral Agents; Artesunate; Drug Combinations; Drug Repositioning; Drug Synergism; Ebolavirus; HeL

2020
Repurposing Quinacrine against Ebola Virus Infection
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:9

    Topics: Animals; Antimalarials; Antiviral Agents; Caco-2 Cells; Chlorocebus aethiops; Disease Models, Animal

2019